Vicki Levidiotis
Austin Research Institute
Department of Nephrology
Austin Health
Melbourne
Australia
Name/email consistency: high
- New insights into the molecular biology of the glomerular filtration barrier and associated disease. Levidiotis, V., Power, D.A. Nephrology. (Carlton) (2005)
- Heparanase inhibition reduces proteinuria in a model of accelerated anti-glomerular basement membrane antibody disease. Levidiotis, V., Freeman, C., Tikellis, C., Cooper, M.E., Power, D.A. Nephrology. (Carlton) (2005)
- Heparanase is involved in the pathogenesis of proteinuria as a result of glomerulonephritis. Levidiotis, V., Freeman, C., Tikellis, C., Cooper, M.E., Power, D.A. J. Am. Soc. Nephrol. (2004)
- A synthetic heparanase inhibitor reduces proteinuria in passive Heymann nephritis. Levidiotis, V., Freeman, C., Punler, M., Martinello, P., Creese, B., Ferro, V., van der Vlag, J., Berden, J.H., Parish, C.R., Power, D.A. J. Am. Soc. Nephrol. (2004)
